Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses
Contexto regulatorio : Cosmtica : aprobado como ingrediente cosmtico en USA (FDA OTC monograph), Unin Europea (CosIng), Japn, Corea, Australia, Mxico (COFEPRIS) y la mayora de jurisdicciones
Secondly, by modifying the surface of nano-particles with liver cell-specific ligands or lipid analogues to target hepatic stellate cells, the enrichment of the drug in specific target cells can be significantly enhanced, reducing off-target effects on normal tissues
In addition, the FDA determined Enzeevu to be interchangeable with its reference medicine, Regenerons Eylea, and the drug holds unexpired exclusivity for first interchangeable biosimilar products
It might be necessary to check ammonia levels on ~250-500 patients to diagnose a single case
Phase 2 trial